Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Moffitt Cancer Center is at the very forefront of cancer centers worldwide in pioneering advances like CAR T-cell therapy, a promising approach to immunotherapy that uses a patient’s own immune cells to recognize and attack their tumors.
Moffitt Cancer Center’s Malignant Hematology Program, one of the largest Myelodysplastic Syndromes (MDS) programs in the nation, provides comprehensive, multispecialty treatment for patients with all forms of MDS and acute myeloid leukemia (AML). They understand that each patient responds differently to therapy, so their experienced team of oncologists, hematologists, medical oncologists, supportive care providers and other team members thoroughly assess each patient’s case to determine the most appropriate options for working toward remission and bringing blood cell counts as close to normal as possible. A patient’s individualized recommendation might include a combination of the following MDS therapies:
• Chemotherapy
• Immunotherapy
• Targeted therapy
• Stem cell and bone marrow transplants
At Moffitt, all MDS therapies are provided in a single location, making it easier for patients to access the outstanding treatments they deserve without the stress of traveling from clinic to clinic.
Related Content
-
UCSF Hellen Diller Family Comprehensive Cancer Center, Comprehensive Amyloidosis ProgramComprehensive Amyloidosis Program is a p...
-
The University of Texas Southwestern Medical CenterThe University of Texas Southwestern Med...
-
Mayo Clinic – MinnesotaMayo Clinic Minnesota is a nonprofit org...
-
Multidisciplinary Cardiac Amyloidosis Center at University of Pittsburgh and University of Pittsburgh Medical CenterThe multi-disciplinary Cardiac Amyloidos...
-
Associazione Italiana Amiloidosi Familiare Onlus (FAMY)L'Associazione Italiana Amiloidosi Famil...
-
Barnes-Jewish Hospital, Washington University Amyloid CenterAt the Washington University Amyloid Cen...
-
North Carolina – Amyloidosis Support Groups Meeting – LIVE – Saturday, September 30, 2023When: Saturday, September 30, 2023 | 9...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.